Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide
1995; Elsevier BV; Volume: 28; Linguagem: Inglês
10.1016/0168-8227(95)01104-l
ISSN1872-8227
Autores Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoIn order to investigate the clinical usefulness of glimepiride in NIDDM, some clinical trials were conducted. In a double-blind comparative study versus gliclazide, glimepiride was as efficacious as gliclazide. However, a subgroup analysis suggested glimepiride may have been more effective in severe patients treated by large doses of gliben-clamide.
Referência(s)